Thanks to receiving the Phase 1 grant, we have performed a thorough feasibility study with a full and robust market-oriented approach. Upon concluding our research, we have decided to continue with the BRAIN project. Our technology roadmap is entirely feasible, including the improvement of our current platform and adaptation for major scalability, machine learning developments, architecture internationalisation and languages as well as other modifications to adapt BRAIN for its international commercialisation. Our objective of developing an online platform providing clear information about insurance policies, user-friendly offer comparison, an easy insurance purchasing process and recommendations to improve coverages has been mostly achieved. We still need to work on the development of machine learning algorithms, including new features in our platform, and adapt our current solution for its international roll out; by doing this during Phase 2 of the project, we are convinced we will achieve all our technical objectives and therefore the readiness of our product to be commercialised.
Our in-depth analysis of the insurance market has given us details of the projected revenues for the coming years in Europe, where our initial target markets are. A comprehensive patent search relating to BRAIN innovations has been undertaken, having confirmed that the project’s results can be exploited freely and further protected. This gives us the freedom to develop and sell our new technology as an innovation which is not currently available in the insurance market and should help us to penetrate our targeted market and countries.
From a financial point of view, we have validated the financial business model with a profitable average gross margin of 65%. We foresee to apply for Phase 2 SME Instrument call next October, in order to complete the project financial needs and reach BRAIN’s commercialisation stage.
Thanks to the H2020 SME Instrument Phase 1, during the last four months we have been able to validate the technical, commercial and financial viability of our novel technology. This Feasibility Study reports the results of the three tasks proposed during the Phase 1 proposal:
Task 1: Technical feasibility assessment: We have identified the technical tasks that we have to accomplish to have a fully operational version of BRAIN. We have outlined a technical plan, which, among other things, will allow us to modify our system architecture, to guarantee the future scalability, and the fine-tuning of our machine learning algorithms. It includes several developing and testing steps and will define all language modifications regarding our international market expansion. We have paid particular attention to those technical risks that could compromise the successful development of BRAIN. We have quantified them with a proper risk assessment methodology and have proposed mitigation measures to reduce the risks.
Task 2: Commercial feasibility assessment: We have analysed the digital insurance brokerage market by identifying our potential end users and their needs. Next, we have paid attention to the global market and have decided on our targets and our penetration strategy. We have also listed and studied our main competitors, including aggregator sites and mobile applications in all market segments and their strengths in the market. Finally, we have elaborated an IPR-analysis to guarantee Freedom-to-Operate for BRAIN;
Task 3: Financial feasibility assessment: Our financial plan includes performing a full cost/benefit analysis, in which we have evaluated the total investment required to achieve the technical developments, prepare the commercial exploitation strategy and validate the economic implications of agreements with insurance companies.